US 10829462
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted A61PA61P1/04A61P17/06
Quick answer
US patent 10829462 (3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors) held by Valo Early Discovery, Inc. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Valo Early Discovery, Inc.
- Grant date
- Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/04, A61P17/06, A61P19/02, A61P19/04